MORN vs STEP

MORN presents a stable but mediocre Piotroski F-Score of 4/9 and lacks a provided Altman Z-Score, indicating a neutral health baseline. The stock is trading at a significant premium to both its Graham Number ($78.33) and Intrinsic Value ($121.96), suggesting substantial overvaluation. This fundamental gap is compounded by a completely bearish technical trend (0/100) and aggressive insider selling totaling over $25M. While the company maintains a strong ROE of 26.35%, the combination of negative price momentum and poor insider sentiment outweighs the optimistic analyst target prices.

StepStone Group presents a stark contrast between explosive growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While revenue growth is exceptional at 73% YoY and analysts maintain a strong buy rating, the company suffers from negative profit margins, negative ROE, and a current ratio below 1.0. The dividend is currently unsustainable with a payout ratio of 167.21%, and heavy insider selling by the CEO and COO suggests a lack of confidence at current valuation levels. The stock is essentially a high-growth play with significant balance sheet risks.